APP and Alzheimer disease: APP mutations such as Swedish, p. Glu693Gly, p. KM670/671NL, and p. V717I have an impact on Aβ production and contribute to AD pathogenesis by increasing Aβ aggregation and plaque formation, cerebral amyloid angiopathy, and cognitive decline [148].